ELK1 and hepatocellular carcinoma: These findings built upon previous data regarding EGR1 expression, in which the activation of ELK1 is required for its expression in HCC cells, following stimulation by the known carcinogen 12-O-tetradecanoylphorbol-13-acetate (TPA) [213].